Document:

First Amendment to the Third Amended and Restated Receivables Purchase Agreement

 Exhibit 10.1 
 EXECUTION COPY 
 FIRST AMENDMENT 
 TO THE 
 THIRD AMENDED AND RESTATED
RECEIVABLES PURCHASE AGREEMENT 
 This FIRST AMENDMENT TO THE THIRD AMENDED AND RESTATED RECEIVABLES PURCHASE AGREEMENT, dated as of
November 13, 2008 (this “Amendment”), is among: 
 (i) CARDINAL HEALTH FUNDING, LLC, a Nevada limited liability company
(the “Seller”); 
 (ii) GRIFFIN CAPITAL, LLC, a Nevada limited liability company (“Griffin” and, together
with the Seller, the “Seller Parties” and each, a “Seller Party”); 
 (iii) RANGER FUNDING COMPANY LLC
(“Ranger”), as a Conduit; 
 (iv) BANK OF AMERICA, N.A. (“BofA”), as the Related Financial Institution for
Ranger and as the Managing Agent for Ranger’s Purchaser Group; 
 (v) WINDMILL FUNDING CORPORATION (“Windmill”), as a
Conduit; 
 (vi) THE ROYAL BANK OF SCOTLAND PLC (as successor to ABN AMRO Bank N.V.) (“RBS”), as the Related Financial
Institution for Windmill and as the Managing Agent for Windmill’s Purchaser Group; 
 (vii) VICTORY RECEIVABLES CORPORATION
(“Victory”), as a Conduit; and 
 (viii) THE BANK OF TOKYO-MITSUBISHI UFJ, LTD., NEW YORK BRANCH
(“BTMUNY”), as the Related Financial Institution for Victory, as Managing Agent for Victory’s Purchaser Group and as the Agent (in such capacity, the “Agent”). 
 Capitalized terms used but not otherwise defined herein have the respective meanings assigned thereto in the RPA (as defined below). 
 PRELIMINARY STATEMENTS 
 WHEREAS, on
November 19, 2007, the Seller Parties, Variable Funding Capital Company, LLC (“VFCC”), as a Conduit, Wachovia Bank, National Association (“Wachovia”), as the Related Financial Institution for VFCC, Wachovia
Capital Markets, LLC (“WCM”), as initial Agent, Victory, as a Conduit, BTMUNY, as the Related Financial Institution for Victory and as the Managing Agent for Victory’s Purchaser Group, Windmill, as a Conduit, and RBS, as the
Related Financial Institution for Windmill and as the Managing Agent for Windmill’s Purchaser Group, entered into that certain Third Amended and Restated Receivables Purchase Agreement (as amended, restated, supplemented or otherwise modified
from time to time, the “RPA”); 

 WHEREAS, immediately prior to the effectiveness of this Amendment, the parties hereto, VFCC, Wachovia and
WCM entered into that certain Assignment and Assumption Agreement, dated as of the date hereof (the “Assignment and Assumption Agreement”), pursuant to which and on the terms and subject to the conditions set forth therein
(i) VFCC assigned all of its rights and obligations as a Conduit under the RPA to Ranger, (ii) Wachovia assigned all of its rights and obligations as a Financial Institution under the RPA to BofA, (iii) Ranger and BofA appointed BofA
as the Managing Agent for their Purchaser Group, (iv) WCM ceased to be the Agent and (v) the remaining Purchasers and Managing Agents appointed BTMUNY as Agent; and 
 WHEREAS, the parties hereto desire to amend the RPA as set forth herein; 
 NOW, THEREFORE, for good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the parties hereto agree as follows: 
 SECTION 1. Amendments to the RPA. The RPA is amended as follows: 
 (a) Each reference in the RPA (and
in any other Transaction Document) to WCM, acting in its capacity as Agent, is replaced with a reference to BTMUNY, acting in its capacity as Agent. 
 (b) Each reference in the RPA (and in any other Transaction Document) to ABN AMRO Bank N.V. (whether by reference to its full name or to “ABN”) is replaced with a reference to The Royal Bank of Scotland plc
or “RBS”, as applicable. In addition, the defined terms “ABN” and “ABN Conduit” and the definitions thereof set forth in Exhibit I to the RPA are replaced with the following, respectively, and moved
to appropriate alphabetical order: 
 “RBS” means The Royal Bank of Scotland plc, a limited liability company
incorporated in Great Britain and registered under the laws of Scotland (as successor to ABN AMRO Bank N.V.), and its successors. 
 “RBS Conduit” means Windmill Funding Corporation and its successors. 
 (c) Section 1.2 of the RPA is
amended by deleting the phrase “the Agent will promptly notify the Wachovia Conduit of such Purchase Notice,” and the phrase “the Agent shall send notice of the proposed Incremental Purchase to the Wachovia Conduit’s Related
Financial Institutions and/or” where they appear therein. 
 (d) Section 1.3 of the RPA is amended by deleting the phrase
“and the Agent will promptly notify each Purchaser in the Wachovia Conduit’s Purchaser Group of such Reduction Notice after the Agent’s receipt thereof” where it appears therein. 
 (e) Section 1.4 of the RPA is replaced in its entirety with the following: 
 Section 1.4 Payment Requirements. All amounts to be paid or deposited by any Seller Party pursuant to any provision of this
Agreement or any other Transaction Documents shall be paid or deposited (or such Seller Party shall initiate a payment or deposit and, if requested, will provide the Agent or any 

  

 2 

 
Managing Agent the related wire confirmation number) in accordance with the terms hereof no later than 12:00 noon (New York time) on the day when due in
immediately available funds, and if not received (or if such payment or deposit is not initiated) before 12:00 noon (New York time) shall be deemed to be received on the next succeeding Business Day. If such amounts are payable to a Purchaser, they
shall be paid to such Purchaser by wire transfer of immediately available funds in accordance with the “Wiring Instructions” specified for such Purchaser on Schedule A or in accordance with such other wiring instructions specified
by such Purchaser (or its Managing Agent) in writing to each other party hereto. If such amounts are payable to the Agent, they shall be paid to the Agent with the “Wiring Instructions” specified for the Agent on Schedule A or in
accordance with such other wiring instructions specified by the Agent in writing to each other party hereto. All computations of Yield, per annum fees or discount calculated as part of any CP Costs, per annum fees hereunder and per annum fees under
any Fee Letter shall be made on the basis of a year of 360 days for the actual number of days elapsed. If any amount hereunder or under any other Transaction Document shall be payable on a day which is not a Business Day, such amount shall be
payable on the next succeeding Business Day. 
 (f) Sub-clause (a) in the first paragraph of Section 6.2 of the RPA
is replaced in its entirety with the following: “(a) in the case of each such Incremental Purchase or Reinvestment, Servicer shall have delivered to the Agent and each Managing Agent on or prior to the date of such purchase, in form and
substance satisfactory to the Agent and such Managing Agent, all Monthly Reports as and when due under Section 8.5 and all Weekly Reports and Daily Reports, if required, as and when due under Section 8.5;”. 

(g) Section 7.1(j)(i) of the RPA is amended by deleting existing sub-clause (C) thereof in its entirety and renumbering
existing sub-clauses (D), (E) and (F) thereof as sub-clauses (C), (D) and (E), respectively. 
 (h) Section 8.5(b) of the RPA is replaced in its entirety with the following: 
 (b) If on any date, less than two of S&P, Moody’s and Fitch are then maintaining senior unsecured long-term debt ratings on Cardinal of at least BBB- (as determined by S&P and Fitch) or Baa3 (as determined by Moody’s),
then the Servicer shall prepare and forward to the Agent and each Managing Agent on the Tuesday of each week thereafter for the immediately preceding calendar week, a Weekly Report with respect to the calendar week most recently ended, which report
shall be in addition to any required or requested Monthly Report. If on any date, less than two of S&P, Moody’s and Fitch are then maintaining senior unsecured long-term debt ratings on Cardinal of at least BB (as determined by S&P and
Fitch) or Ba2 (as determined by Moody’s), the Servicer shall prepare and forward to the Agent and each Managing Agent on each Business Day thereafter, a Daily Report with respect to the immediately preceding Business Day or such other Business
Day determined by the Agent, which report shall be in addition to any required or requested Monthly Report. 
  

 3 

 (i) Section 9.1(g)(i) of the RPA is replaced in its entirety with the following: 

(i) (x) the Collections-to-Sales Ratio for such calendar month shall be less than 75% or (y) the Collections-to-Sales Ratios for
each of such calendar month and the immediately preceding calendar month shall be less than 80%; or 
 (j) Section 10.2 of the
RPA is replaced in its entirety with the following: 
 Section 10.2 Increased Cost and Reduced Return; Accounting
Based Consolidation Events. 
 (a) If any Funding Source shall be charged any fee, expense or increased cost on account of
the adoption of any applicable law, rule or regulation (including any applicable law, rule or regulation regarding capital adequacy), any accounting principles or any change in any of the foregoing, or any change in the interpretation or
administration thereof by the Financial Accounting Standards Board (“FASB”), any governmental authority, any central bank or any comparable agency charged with the interpretation or administration thereof, or compliance with any
request or directive (whether or not having the force of law) of any such authority or agency (a “Regulatory Change”): (i) that subjects any Funding Source to any charge or withholding on or with respect to any Funding
Agreement or a Funding Source’s obligations under a Funding Agreement, or on or with respect to the Receivables, or changes the basis of taxation of payments to any Funding Source of any amounts payable under any Funding Agreement (except for
changes in the rate of tax on the overall net income of a Funding Source) or (ii) that imposes, modifies or deems applicable any reserve, assessment, insurance charge, special deposit or similar requirement against assets of, deposits with or
for the account of a Funding Source, or credit extended by a Funding Source pursuant to a Funding Agreement or (iii) that imposes any other condition the result of which is to increase the cost to a Funding Source of performing its obligations
under a Funding Agreement, or to reduce the rate of return on a Funding Source’s capital as a consequence of its obligations under a Funding Agreement, or to reduce the amount of any sum received or receivable by a Funding Source under a
Funding Agreement or to require any payment calculated by reference to the amount of interests or loans held or interest received by it, then, upon demand by the Agent, Seller will pay to the Agent, for the benefit of the relevant Funding Source,
such amounts charged to such Funding Source or such amounts to otherwise compensate such Funding Source for such increased cost or such reduction, provided, however, that such fee, expense or increased cost is applicable generally to the class of
institutions of which such Funding Source is a member. For the avoidance of doubt, if FASB Interpretation No. 46R, or any other change in accounting standards or the issuance of any other pronouncement, release or interpretation, causes or
requires the consolidation of all or a portion of the assets and liabilities of any Conduit or Seller with the assets and liabilities of any Funding Source, such event shall constitute a circumstance on which such Funding Source may base a claim for
reimbursement under this Section 10.2(a). 
  

 4 

 (b) Without limiting the generality of the forgoing clause (a), if after the date
hereof, any Accounting Based Consolidation Event shall occur which is not the result of a Regulatory Change, then, upon demand by the Agent, Seller shall pay to the Agent, for the benefit of the relevant Funding Source, such amounts as such Funding
Source reasonably determines will compensate or reimburse such Funding Source for any resulting (i) fee, expense or increased cost charged to, incurred or otherwise suffered by such Funding Source, (ii) reduction in the rate of return on
such Funding Source’s capital or reduction in the amount of any sum received or receivable by such Funding Source, or (iii) internal capital charge or other imputed cost determined by such Funding Source to be allocable to Seller or the
transactions contemplated in this Agreement in connection therewith; provided, however, that in no event may any Funding Source (or the Agent on its behalf) claim or receive reimbursement or compensation for amounts under this
Section 10.2(b) that would result in its total compensation (inclusive of Yield and fees) exceeding the total compensation that would have been payable to such Funding Source immediately prior to such Accounting Based Consolidation Event
if it were a Related Financial Institution purchasing or committing to purchase Purchaser Interests pursuant to Section 1.2 of this Agreement. For the avoidance of doubt, the limitation set forth in the foregoing proviso shall not
be construed to limit any Funding Source’s right to payment pursuant to Section 10.2(a) above. Amounts payable by Seller under this Section 10.2(b) may be demanded at any time without regard to the timing of issuance of
any financial statement by any Conduit or by any Funding Source. 
 (k) Sub-clause (iii) of Section 12.1(b) of the
RPA is replaced in its entirety with the following: “(iii) be approved by Seller (such approval not to be unreasonably withheld or delayed); provided, however, that no such approval of the Seller shall be required (A) in the
case of an assignment by an Affected Financial Institution pursuant to Section 12.1(c), (B) in the event that Seller does not approve of the proposed Purchasing Financial Institution and Seller, the Agent, such Conduit and the
selling Financial Institution fail to agree on an alternative funding entity within 15 days after the selling Financial Institution gives notice pursuant to this Section 12.1(b) of the proposed assignment or (C) if an Amortization
Event or a Potential Amortization Event shall have occurred and is continuing.” 
 (l) Section 13.1 of the RPA is amended by
deleting the parenthetical “(other than the Wachovia Conduit’s Purchaser Group)” where it appears therein. 
 (m)
Section 14.1(b)(i) of the RPA is amended by replacing sub-clause (G) thereof in its entirety with “(G) change the definition of “Eligible Receivable,” “Loss Reserve,” “Dilution Reserve,”
“Carrying Cost Reserve,” “Aggregate Reserves,” “Dynamic Reserve” or “Reserve Floor”“. 
 (n)
Section 14.5(b) of the RPA is amended by replacing the reference to “Wachovia” where it appears therein with a reference to “the Agent”. 
  

 5 

 (o) Section 14.13 of the RPA is replaced in its entirety with the following: 
 Section 14.13 Agent Roles. In addition to its role as Agent pursuant to Article XI, each of the Purchasers and Managing
Agents acknowledges that the Person acting as Agent (or any Affiliate thereof) acts, or may in the future act, (i) as a Financial Institution or a Managing Agent party hereto, (ii) as administrative agent (or in a similar capacity) for a
Conduit, Financial Institution or Managing Agent from time to time party hereto or for any other Person, (iii) as issuing and paying agent for certain Commercial Paper, (iv) to provide credit or liquidity enhancement for the timely payment
for certain Commercial Paper and (v) to provide other services from time to time for a Conduit, Financial Institution or Managing Agent from time to time party hereto or for any other Person (collectively, the “Agent Roles”).
Without limiting the generality of this Section 14.13, each Purchaser and each Managing Agent hereby acknowledges and consents to any and all Agent Roles and agrees that in connection with any Agent Role, the Person acting as Agent may
take, or refrain from taking, any action that it, in its discretion, deems appropriate, including, without limitation, in its role as administrative agent for a Conduit party hereto. 
 (p) The following defined terms and the definitions thereof set forth in Exhibit I to the RPA are deleted therefrom in their entirety: 

(i) “Interim Monthly Report”; 
 (ii) “Net Dilution Percentage”; 
 (iii) “JPMC CHI Account”; 
 (iv) “Servicing Reserve”; 
 (v) “Wachovia”; 
 (vi) “Wachovia Bank”; and 
 (vii) “Wachovia Conduit”. 
 (q) The following new defined terms and definitions thereof are
added to Exhibit I to the RPA in appropriate alphabetical order: 
 “Accounting Based Consolidation
Event” means the consolidation, for financial and/or regulatory accounting purposes, of all or any portion of the assets and liabilities of any Conduit that are subject to this Agreement or any other Transaction Document with all or any
portion of the assets and liabilities of any Funding Source. An Accounting Based Consolidation Event shall be deemed to occur on the date any Funding Source shall acknowledge in writing that any such consolidation of the assets and liabilities of a
Conduit shall occur. 
 “BofA” means Bank of America, N.A. and its successors. 
 “BofA Conduit” means Ranger Funding Company LLC and its successors. 
  

 6 

 “Carrying Cost Reserve” means, on any date of determination, an amount
equal to the sum of (a) all accrued and unpaid Conduit Costs, Yield and fees and any other amounts payable by the Seller under the Fee Letters plus (b) the product of (i) the Carrying Cost Reserve Percentage multiplied by
(ii) the Net Receivables Balance as of the close of business of the Servicer on such date. 
 “Carrying Cost
Reserve Percentage” means, on any date of determination, a fraction (expressed as a percentage) (a) the numerator of which is the product of (i) 2.25 multiplied by (ii) the sum of (x) the Prime Rate then in effect plus
(y) 5.00% multiplied by (iii) Days Sales Outstanding and (b) the denominator of which is 360. 
 “Days
Sales Outstanding” means, on any date of determination, an amount (expressed in days) equal to the product of (a) the amount obtained by dividing (i) the aggregate Outstanding Balance of all Receivables as of the last day of the
most recently ended calendar month by (ii) the aggregate Outstanding Balance of all Receivables that were originated during such calendar month multiplied by (b) 30. 
 “Dynamic Reserve” means, on any date of determination, an amount equal to the sum of (i) the Dilution Reserve plus
(ii) the Loss Reserve. 
 “Loss Stress Factor” means, at any time, the “Loss Stress Factor”
set forth in the table below corresponding to the Ratings Level in effect at such time and set forth in the table below. 
  

			
	 Ratings Level
	  	Loss Stress
Factor
	 Ratings Level 1
	  	2.25
	 Ratings Level 2
	  	2.25
	 Ratings Level 3
	  	2.50
	 Ratings Level 4
	  	2.50

 “Reserve Floor” means, on any date of determination, an amount
equal to the product of (i) the Reserve Floor Percentage multiplied by (ii) the Net Receivables Balance as of the close of business of the Servicer on such date. 
 “Reserve Floor Percentage” means, on any date of determination, a percentage equal to the sum of (i) 21% plus
(ii) the product of (x) the Expected Dilution Ratio multiplied by (y) the Dilution Horizon Ratio. 
 (r) The definition of
“Aggregate Reserves” set forth in Exhibit I to the RPA is replaced in its entirety with the following: 
  

 7 

 “Aggregate Reserves” means, on any date of determination, an amount
equal to the sum of (i) the greater of (x) the Reserve Floor and (y) the Dynamic Reserve plus (ii) the Carrying Cost Reserve. 
 (s) The definition of “Applicable Margin” set forth in Exhibit I to the RPA is amended by replacing the percentage “0.425%” where it appears therein with the percentage “2.50%”. 
 (t) The definition of “Collection Account” set forth in Exhibit I to the RPA is replaced in its entirety with the following:

 “Collection Account” means each concentration account, depositary account, lock-box account or similar
account in which any Collections are collected or deposited, including, without limitation, any account established for the purposes of receiving Collections which are paid by automated clearing house (ACH) or wire transfer.

 (u) The definition of “Collection Account Disclosure Letter” set forth in Exhibit I to the RPA is replaced in its
entirety with the following: 
 “Collection Account Disclosure Letter” means that certain letter between the
Seller and the Agent dated November 13, 2008 identifying, among other things, the Collection Banks and the Collection Accounts. 
 (v)
The definition of “Default Fee” set forth in Exhibit I to the RPA is amended by replacing the percentage “2%” where it appears therein with the percentage “2.50%”. 
 (w) The definition of “Default Ratio” set forth in Exhibit I to the RPA is amended by replacing the phrase “the calendar
month three calendar months prior to such calendar month” where it appears in clause (ii) thereof with the phrase “the calendar month that is four calendar months prior to such calendar month”. 
 (x) The definition of “Dilution Horizon Ratio” set forth in Exhibit I to the RPA is replaced in its entirety with the following:

 “Dilution Horizon Ratio” means, as of the last day of any calendar month, a percentage equal to
(i) the sum of (x) the aggregate gross sales of the Originators during the calendar month then most recently ended plus (y) 33% of the aggregate gross sales of the Originators during the calendar month immediately preceding the
calendar month then most recently ended, divided by (ii) the Net Receivables Balance as of the last day of the most recently ended calendar month. 
 (y) The definition of “Dilution Reserve” set forth in Exhibit I to the RPA is amended by replacing the reference therein to “the Net Dilution Percentage” with “the Dilution
Percentage”. 
  

 8 

 (z) The definition of “Dilution Stress Factor” set forth in Exhibit I to the RPA
is replaced in its entirety with the following: 
 “Dilution Stress Factor” means, at any time, the
“Dilution Stress Factor” set forth in the table below corresponding to the Ratings Level in effect at such time and set forth in the table below. 
  

			
	 Ratings Level
	  	Dilution Stress
Factor
	 Ratings Level 1
	  	2.25
	 Ratings Level 2
	  	2.25
	 Ratings Level 3
	  	2.50
	 Ratings Level 4
	  	2.50

 (aa) The definition of “Funding Source” set forth in Exhibit I to the RPA
is replaced in its entirety with the following: 
 “Funding Source” means with respect to any Conduit
(i) such Conduit’s Related Financial Institution(s), (ii) such Conduit’s related Managing Agent, (iii) any insurance company, bank or other funding entity providing liquidity, credit enhancement or back-up purchase support
or facilities to such Conduit, (iv) any agent, administrator or manager of such Conduit and (v) any bank holding company related to any of the foregoing. 
 (bb) The definition of “LIBO Rate” set forth in Exhibit I to the RPA is replaced in its entirety with the following: 
 “LIBO Rate” means, with respect to any Tranche Period and any Purchaser, the sum of (i) (a) either (x) the
interest rate per annum designated as LIBOR for the Related Financial Institution for a period of time comparable to such Tranche Period that appears on the Reuters Screen LIBOR01 Page (or on any successor or substitute page thereof, or any
successor to or substitute for such service, providing rate quotations comparable to those currently provided on the Reuters Screen LIBOR01 Page, as determined by the related Managing Agent from time to time for purposes of providing quotations of
interest rates applicable to dollar deposits in the London interbank market) as of 11:00 a.m. (London, England time) on the second Business Day preceding the first day of such Tranche Period or (y) if a rate cannot be determined under clause
(x) above, a rate per annum equal to the average (for purposes of this clause (y), rounded upwards, if necessary, to the nearest one-hundredth of a percentage point) of the rates per annum at which deposits in U.S. dollars in the approximate
amount to be funded at the LIBO Rate and having a maturity equal to such Tranche Period are offered to the principal London office of such Related Financial Institution by three London banks, selected by such Related Financial Institution in good
faith, at about 11:00 a.m. London time on the second Business Day preceding the first day of such Tranche Period, divided by (b) one minus the maximum aggregate reserve 

  

 9 

 
requirement (including all basic, supplemental, marginal or other reserves) which is imposed against such Related Financial Institution in respect of
Eurocurrency liabilities, as defined in Regulation D of the Board of Governors of the Federal Reserve System as in effect from time to time (expressed as a decimal), applicable to such Tranche Period, plus (ii) the Applicable Margin. The LIBO
Rate shall be rounded, if necessary, to the next higher  1/16 of 1%. 
 (cc) The definition of “Liquidity Termination Date” set forth in Exhibit I to the RPA is amended by replacing the date
“November 17, 2008” where it appears therein with the date “November 12, 2009”. 
 (dd) The definition of “Loss
Horizon Ratio” set forth in Exhibit I to the RPA is amended by replacing the words “the three most recently ended calendar months” where they appear in clause (i) thereof with “the four most recently ended
calendar months”. 
 (ee) The definition of “Loss Percentage” set forth in Exhibit I to the RPA is replaced in
its entirety with the following: 
 “Loss Percentage” means, at any time, a percentage equal to the product
of (i) Loss Stress Factor multiplied by (ii) the Loss Ratio multiplied by (iii) the Loss Horizon Ratio. 
 (ff) The definition
of “Prime Rate” set forth in Exhibit I to the RPA is amended by replacing the reference to “Wachovia Bank, N.A.” where it appears therein with a reference to “the Agent”. 
 (gg) The definition of “Required Notice Period” set forth in Exhibit I to the RPA is amended by replacing each reference to the
amount “$320,000,000” therein with a reference to the amount “$250,000,000”. 
 (hh) Each of Exhibit II,
Exhibit IX, Exhibit XI, Exhibit XII, Schedule A and Schedule C to the RPA is replaced in its entirety with new Exhibit II, Exhibit IX, Exhibit XI, Exhibit XII, Schedule A and
Schedule C, respectively, attached hereto. 
 SECTION 2. Representations and Warranties. 
 On the date hereof, each Seller Party hereby represents and warrants (as to itself) to the Purchasers, the Managing Agents and the Agent that: 

(a) after giving effect to this Amendment, no event or condition has occurred and is continuing which constitutes an Amortization Event or Potential
Amortization Event; 
 (b) after giving effect to this Amendment, the representations and warranties of such Seller Party set forth in the
RPA and each other Transaction Document are true and correct as of the date hereof, as though made on and as of such date (except to the extent such representations and warranties relate solely to an earlier date and then as of such earlier date);
and 
  

 10 

 (c) this Amendment constitutes the valid and binding obligation of such Seller Party, enforceable against
such Seller Party in accordance with its terms. 
 SECTION 3. Conditions to Effectiveness. 
 This Amendment shall become effective as of the date hereof upon (i) receipt by the Agent of counterparts of this Amendment, duly
executed by each of the parties hereto, (ii) receipt by the Agent of each other agreement, writing and opinion reliance letter listed on Exhibit A and (iii) receipt by each Managing Agent of the “Structuring Fee” payable
by the Seller to such Managing Agent’s Purchaser Group under such Purchaser Group’s Fee Letter (as amended and restated on the date hereof). 
 SECTION 4. Counterparts; Delivery. 
 This Amendment may be executed in any number of counterparts and
by different parties on separate counterparts, and each counterpart shall be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument. Delivery of an executed counterpart of a signature page to
this Amendment by facsimile or other electronic means shall be effective as delivery of a manually executed counterpart of this Amendment. 
 SECTION 5.
Effect of Amendment; Ratification. 
 Except as specifically amended and waived hereby, the RPA is hereby ratified and confirmed in all
respects, and all of its provisions shall remain in full force and effect. After this Amendment becomes effective, all references in the RPA (or in any other Transaction Document) to “the Receivables Purchase Agreement”, “this
Agreement”, “hereof”, “herein”, or words of similar effect, in each case referring to the RPA, shall be deemed to be references to the RPA as amended hereby. This Amendment shall not be deemed to expressly or impliedly
waive, amend, or supplement any provision of the RPA other than as specifically set forth herein. 
 SECTION 6. GOVERNING LAW. 
 THIS AMENDMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE INTERNAL LAWS OF THE STATE OF ILLINOIS. 
 SECTION 7. Section Headings. 
 The various headings of
this Amendment are inserted for convenience only and shall not affect the meaning or interpretation of this Amendment or the RPA or any provision hereof or thereof. 
 [Signatures pages follow.] 
  

 11 

 IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be executed by their respective
officers thereunto duly authorized, as of the date first above written. 
  

			
	CARDINAL HEALTH FUNDING, LLC,
	as Seller
		
	By:	 	 /s/ Jeffery W. Proctor

	Name:	 	Jeffery W. Proctor
	Title:	 	President
	
	 GRIFFIN CAPITAL, LLC,
 as
Servicer

		
	By:	 	 /s/ Jeffery W. Proctor

	Name:	 	 Jeffery W. Proctor

	Title:	 	President

 First Amendment to the Third Amended and 
 Restated Receivables Purchase Agreement 
  

 S-1 

			
	RANGER FUNDING COMPANY LLC,
	as a Conduit
		
	By:	 	 /s/ Doris J. Hearn

	Name:	 	Doris J. Hearn
	Title:	 	Vice President
	
	 BANK OF AMERICA, N.A.,
 as Related Financial
Institution for Ranger

		
	By:	 	 /s/ Leif E. Rauer

	Name:	 	Leif E. Rauer
	Title:	 	Vice President
	
	 BANK OF AMERICA, N.A.,
 as Managing Agent for
Ranger’s Purchaser Group

		
	By:	 	 /s/ Leif E. Rauer

	Name:	 	Leif E. Rauer
	Title:	 	Vice President

 First Amendment to the Third Amended and 
 Restated Receivables Purchase Agreement 
  

 S-2 

					
	WINDMILL FUNDING CORPORATION,
	as a Conduit
		
	By:	 	 /s/ Jill A. Russo

	Name:	 	Jill A. Russo
	Title:	 	Vice President
	
	 THE ROYAL BANK OF SCOTLAND PLC,
 as Related
Financial Institution for Windmill

			
		 	By:	 	Greenwich Capital Markets, Inc., as agent
		
	By:	 	 /s/ David Viney

	Name:	 	David Viney
	Title:	 	Managing Director
	
	 THE ROYAL BANK OF SCOTLAND PLC,
 as Managing
Agent for Windmill’s Purchaser Group

			
		 	By:	 	Greenwich Capital Markets, Inc., as agent
		
	By:	 	 /s/ David Viney

	Name:	 	David Viney
	Title:	 	Managing Director

 First Amendment to the Third Amended and 
 Restated Receivables Purchase Agreement 
  

 S-3 

			
	VICTORY RECEIVABLES CORPORATION,
	as a Conduit
		
	By:	 	 /s/ Louie E. Colby

	Name:	 	Louie E. Colby
	Title:	 	Vice President
	
	 THE BANK OF TOKYO-MITSUBISHI UFJ, LTD.,
 NEW
YORK BRANCH,
 as Related Financial Institution for Victory

		
	By:	 	 /s/ Victor Pierzchalski

	Name:	 	Victor Pierzchalski
	Title:	 	Authorized Signatory
	
	 THE BANK OF TOKYO-MITSUBISHI UFJ, LTD.,
 NEW
YORK BRANCH,
 as Managing Agent for Victory’s Purchaser Group

		
	By:	 	 /s/ Van Dusenbury

	Name:	 	Van Dusenbury
	Title:	 	Senior Vice President
	
	 THE BANK OF TOKYO-MITSUBISHI UFJ, LTD.,
 NEW
YORK BRANCH,
 as Agent

		
	By:	 	 /s/ Van Dusenbury

	Name:	 	Van Dusenbury
	Title:	 	Senior Vice President

 First Amendment to the Third Amended and 
 Restated Receivables Purchase Agreement 
  

 S-4 

 Acknowledged and Agreed to by: 
  

			
	 CARDINAL HEALTH, INC. , as
 Performance
Guarantor

		
	By:	 	 /s/ Linda S. Harty

	Name:	 	Linda S. Harty
	Title:	 	Executive Vice President and Treasurer

 First Amendment to the Third Amended and 
 Restated Receivables Purchase Agreement 
  

 S-5 

 EXHIBIT A 
 CLOSING INDEX 
 THE CARDINAL HEALTH FUNDING, LLC SECURITIZATION 
 RESTRUCTURING AND RENEWAL 
 Closing Date:
November 13, 2008 
 Parties & Abbreviations: 
  

			
	 BoA
	  	Bank of America, N.A.
	 BTMU
	  	The Bank of Tokyo-Mitsubishi UFJ, Ltd., New York Branch
	 Cardinal
	  	Cardinal Health, Inc., an Ohio corporation
	 Cardinal 2
	  	Cardinal Health 2, Inc.
	 CH-110
	  	Cardinal Health 110, Inc., a Delaware corporation
	 CH-411
	  	Cardinal Health 411, Inc., an Ohio corporation
	 Funding
	  	Cardinal Health Funding, LLC, a Nevada limited liability company
	 Griffin
	  	Griffin Capital, LLC, a Nevada limited liability company
	 JPM
	  	JPMorgan Chase Bank, N.A.
	 K&L
	  	Kolesar & Leatham, Chtd.
	 L&W
	  	Latham & Watkins LLP
	 MB
	  	Mayer Brown LLP
	 PNC
	  	PNC Bank, National Association
	 Ranger
	  	Ranger Funding Company LLC
	 RBS
	  	The Royal Bank of Scotland plc (as successor to ABN AMRO Bank N.V.)
	 VFCC
	  	Variable Funding Capital Company
	 Victory
	  	Victory Receivables Corporation
	 Wachovia
	  	Wachovia Bank, National Association
	 WCM
	  	Wachovia Capital Markets, LLC
	 Windmill
	  	Windmill Funding Corporation

  

 Ex. A-1 

			
	 Document
	  	 Signatures Needed

	 A. DOCUMENTS
	  	
	 1. Assumption and Assignment Agreement
	  	 Cardinal
 Griffin
 Funding
 VFCC
 Wachovia
 WCM
 Ranger

BoA
 Windmill
 RBS
 Victory
 BTMU

		
	 2. First Amendment to the Third Amended and Restated Receivables Purchase Agreement
	  	 Funding
 Griffin
 Ranger
 BoA
 Windmill
 RBS
 Victory

BTMU
 Cardinal

		
	 3. Reaffirmation of Performance Guaranty
	  	Cardinal
		
	 4. Assignment and Assumption of Deposit Account Control Agreement with Wachovia, Bank, National Association
	  	 Wachovia (as Depositary Bank)
 WCM
 BTMU

		
	 5. Deposit Account Control Agreement Assignment and Assumption Agreement relating to the Five Party Agreement Relating to Lockbox Services
with Bank of America, N.A.
	  	 WCM
 Funding
 Griffin
 BTMU
 BoA (as depositary bank)

		
	 6. Deposit Account Control Agreement Assignment, Assumption and Amendment Agreement relating to the Amended and Restated Collection Account
Agreement with PNC Bank, National Association
	  	 WCM
 Funding
 Griffin
 Cardinal
 CH-110
 PNC
 BTMU

		
	 7. Second Amendment to Cash Management Agreement
	  	 Cardinal
 Griffin
 CH-411
 CH-110
 Funding
 Cardinal 2
 BTMU
 RBS
 BoA

  

 Ex. A-2 

			
	 Document
	  	 Signatures Needed

	 8. Collection Account Disclosure Letter
	  	 Funding
 BTMU

		
	 9. Amended and Restated Fee Letter for BTMU and Victory
	  	 Funding
 BTMU
 Victory

		
	 10. Amended and Restated Fee Letter for RBS and Windmill
	  	 Funding
 RBS
 Windmill

		
	 11. Amended and Restated Fee Letter for BoA and Ranger
	  	 Funding
 BoA
 Ranger

		
	 12. Power of Attorney in favor of BTMU
	  	Funding
		
	 D. LEGAL OPINIONS
	  	
	 13. Reliance Letter by L&W
	  	L&W
		
	 14. Reliance Letter by K&L
	  	K&L
		
	 15. Reliance Letter(s) by Cardinal in house counsel
	  	 Cardinal’s In-House
 Counsel

		
	 E. CORPORATE DOCUMENTS AND CERTIFICATES
	  	
	 16. Secretary Certificate of Funding as to:
	  	Funding
	 a. Resolutions of the Board of Directors
	  	
	 b. Certificate of Incorporation
	  	
	 c. By-laws
	  	
	 d. Incumbency and Signature
	  	
		
	 17. Secretary Certificate of Griffin as to:
	  	Griffin
	 a. Resolutions of the Board of Directors
	  	
	 b. Certificate of Incorporation
	  	
	 c. By-laws
	  	
	 d. Incumbency and Signature
	  	
		
	 18. Secretary Certificate of CH-110 as to:
	  	CH-110
	 a. Resolutions of the Board of Directors
	  	
	 b. Certificate of Incorporation
	  	
	 c. By-laws
	  	
	 d. Incumbency and Signature
	  	
		
	 19. Secretary Certificate of CH-411 as to:
	  	CH-411
	 a. Resolutions of the Board of Directors
	  	
	 b. Certificate of Incorporation
	  	
	 c. By-laws
	  	
	 d. Incumbency and Signature
	  	

  

 Ex. A-3 

			
	 Document
	  	 Signatures Needed

	 20. Secretary Certificate of Cardinal as to:
	  	Cardinal
	 a. Resolutions of the Board of Directors
	  	
	 b. Certificate of Incorporation
	  	
	 c. By-laws
	  	
	 d. Incumbency and Signature
	  	
		
	 21. Good standing certificate for Funding from Nevada
	  	N/A
		
	 22. Good standing certificate for Griffin from Nevada
	  	N/A
		
	 23. Good standing certificate for CH-110 from Delaware
	  	N/A
		
	 24. Good standing certificate for CH-411 from Ohio
	  	N/A
		
	 25. Good standing certificate for Cardinal from Ohio
	  	N/A
		
	 26. Compliance Certificate of Funding in the form of Exhibit V to the Third Amended and Restated Receivables Purchase
Agreement
	  	 CH-411
 CH-110
 Funding
 Griffin

		
	 F. MISCELLANEOUS DOCUMENTS
	  	
	 27. UCC-3 for all filings listed in Exhibit A pertaining to Cardinal Health Funding, LLC changing secured party of record from WCM to BTMU

	  	N/A
		
	 28. UCC-3 for all filings listed in Exhibit A pertaining to Griffin Capital, LLC changing secured party of record from WCM to
BTMU
	  	N/A

  

 Ex. A-4 

			
	 Document
	  	 Signatures Needed

	 29. UCC-3 for all filings listed in Exhibit A pertaining to Cardinal Health 411, Inc. changing secured party of record from WCM to
BTMU
	  	N/A
		
	 30. UCC-3 for all filings listed in Exhibit A pertaining to Cardinal Health 410, Inc. changing secured party of record from WCM to
BTMU
	  	N/A
		
	 31. UCC-3 continuation statement, continuing financing statement #2004016520-0 filed 5/25/2004 with the Secretary of State of Nevada (do not
file before 11/26/2008)
	  	N/A
		
	 32. UCC-3 continuation statement, continuing financing statement #2004016603-6 filed 5/25/2004 with the Secretary of State of Nevada (do not
file before 11/26/2008)
	  	N/A
		
	 33. UCC-3 continuation statement, continuing financing statement #41446121 filed 5/25/2004 with the Secretary of State of Delaware (do not
file before 11/26/2008)
	  	N/A
		
	 34. “Bring Down” lien searches against Cardinal Health Funding, LLC, beginning 10/8/2007 from (i) Secretary of State, Nevada
(UCC, Federal tax liens), (ii) Clark County, NV (Federal/State tax liens, judgment liens at County Recorder and local litigation at District Court), (iii) US Bankruptcy Court, Nevada District (bankruptcy) and (iv) US District Court,
Nevada District (Federal litigation).
	  	N/A
		
	 35. “Bring Down” lien searches against Griffin Capital, LLC, beginning 10/8/2007 from (i) Secretary of State, Nevada (UCC,
Federal tax liens), (ii) Clark County, NV (Federal/State tax liens, judgment liens at County Recorder and local litigation at District Court), (iii) US Bankruptcy Court, Nevada District (bankruptcy) and (iv) US District Court, Nevada
District (Federal litigation).
	  	N/A
		
	 36. “Bring Down” lien searches against Cardinal Health 411, Inc., beginning 10/31/2007 from (i) Secretary of State, OH (UCC),
(ii) Delaware County, OH (Federal tax liens at County Recorder, State tax liens, judgment liens and local litigation at Court of Common Pleas), (iii) Franklin County, OH (Federal tax liens at County Recorder, State tax liens, judgment
liens and local litigation at Court of Common Pleas), (iv) US Bankruptcy Court, Southern District, OH (bankruptcy) and (v) US District Court, Southern District, OH (Federal litigation)
	  	N/A
		
	 37. “Bring Down” lien searches against Cardinal Health 110, Inc., beginning 9/6/2007 from (i) Secretary of State, Delaware
(UCC, Federal tax liens), (ii) New Castle County, DE (Federal tax liens at Recorder of Deeds, State tax liens at prothonotary, local litigation at Superior and Chancery courts, judgment liens at prothonotary), (iii) US Bankruptcy Court,
Delaware District (Bankruptcy) and (iv) US District Court, Delaware District (Federal litigation)
	  	N/A

  

 Ex. A-5 

 EXHIBIT A TO CLOSING INDEX 
 Debtor: Cardinal Health Funding, LLC (A Nevada LLC) 
  

					
	 Jurisdiction
	  	Original Financing Statement
Number/Date of Filing	  	Assignment Number/Date of Filing
	 Secretary of State-Nevada
	  	0010231                7/5/2000 	  	2007038528-8     11/19/2007
			
	 Secretary of State-Nevada
	  	2003014202-2       5/23/2003	  	2007038527-6     11/19/2007
			
	 Secretary of State-Nevada
	  	2004016520-0       5/25/2004	  	2007038526-4     11/19/2007
			
	 Secretary of State-Nevada
	  	2004030249-2       10/4/2004	  	2007038525-2     11/19/2007
			
	 Secretary of State-Nevada
	  	2006036964-8       11/6/2006	  	2007038524-0     11/19/2007
			
	 Secretary of State-Nevada
	  	2008025580-5       8/15/2008	  	N/A (New filing identical to
 2003014202-2 filed
 5/23/2003)

 Debtor: Griffin Capital, LLC (a Nevada LLC) 
  

					
	 Jurisdiction
	  	Original Financing Statement
Number/Date of Filing	  	Assignment Number/Date of Filing
	 Secretary of State-Nevada
	  	0010230               7/5/2000 	  	2007038522-6     11/19/2007
			
	 Secretary of State-Nevada
	  	2002017712-4     7/3/2002 	  	2007038519-9     11/19/2007
			
	 Secretary of State-Nevada
	  	2002017713-6     7/3/2002 	  	2007038523-8     11/19/2007
			
	 Secretary of State-Nevada
	  	2004016603-6     5/25/2004	  	2007038520-2     11/19/2007
			
	 Secretary of State-Nevada
	  	2004030250-5     10/4/2004	  	2007038521-4     11/19/2007

 Debtor: Cardinal Health 411, Inc. (an Ohio corporation) 
  

					
	 Jurisdiction
	  	Original Financing Statement
Number/Date of
Filing	  	Assignment Number/Date of Filing

  

 Ex. A-6 

					
	 Secretary of State-Ohio
	  	OH00116501041     6/21/2007	  	20073250272     11/19/2007

 Debtor: Cardinal Health 110, Inc. (a Delaware corporation) 
  

					
	 Jurisdiction
	  	Original Financing Statement
Number/Date of Filing	  	Assignment Number/Date of Filing
	 Secretary of State-Delaware
	  	0042114     7/5/2000 	  	2007 4406798     11/19/2007
			
	 Secretary of State-Delaware
	  	20084867   1/11/2002	  	2007 4406822     11/19/2007
			
	 Secretary of State-Delaware
	  	20085260   1/11/2002	  	2007 4406863     11/19/2007
			
	 Secretary of State-Delaware*
	  	41446121   5/25/2004	  	2007 4406897     11/19/2007

  

	*	This filing, until the 11/19/07 assignment, still in name of Bank One, N.A. (Main Office Chicago), as Agent 

  

 Ex. A-7 

 EXHIBIT II 
 FORM OF PURCHASE NOTICE 
 [Date] 
 The Bank of Tokyo-Mitsubishi UFJ, Ltd., New York Branch, as Agent and a Managing Agent 
 12th Floor 
 1251 Avenue
of the Americas 
 New York, NY 10020 
 Attention: Hermina Batson

 The Royal Bank of Scotland plc, as a Managing Agent 
 540 West
Madison Street, 27th Floor 
 Chicago, IL 60661 
 Attention:
Kristina Neville, Sheila Brooks & Sharon Jones 
 Bank of America, N.A., as a Managing Agent 
 NC1-027-19-01 
 214 North Tryon Street 
 Charlotte, NC 28255 
 Attention: Nina Stevenson 
                                         
Re: PURCHASE NOTICE  
 Ladies and Gentlemen: 
 Reference is hereby made to the Third Amended and Restated Receivables Purchase Agreement, dated as of November 19, 2007, as amended, by and among Cardinal Health Funding, LLC, a Nevada limited liability company (the
“Seller”), Griffin Capital, LLC, as Servicer, the Financial Institutions, the Conduits, the Managing Agents and The Bank of Tokyo-Mitsubishi UFJ, Ltd., New York Branch, as Agent (the “Receivables Purchase
Agreement”). Capitalized terms used herein shall have the meanings assigned to such terms in the Receivables Purchase Agreement. 
 Each of the Agent and each Managing Agent is hereby notified of the following Incremental Purchase: 
  

			
	 Purchase Price:
	  	$                                        
                        

  

 Ex. II-1 

			
	 Portion of the Purchase Price Payable by the BofA Conduit’s Purchaser Group:1

	  	$                                        
                        
		
	 Portion of Purchase Price Payable by the BTMU Conduit’s Purchaser Group:2
	  	$                                        
                        
		
	 Portion of Purchase Price Payable by the RBS Conduit’s Purchaser Group:3
	  	$                                       
                         
		
	 Date of Purchase:
	  	
		
	 Requested Discount Rate:
	  	[LIBO Rate] [Prime Rate] [Pooled Commercial Paper rate] [Special Pooled Commercial Paper rate]
		
	 Requested Tranche Period:
	  	[                                       
                         ]
		
		  	

 Please credit the Purchase Price in immediately available funds to our Facility Account [and then
wire-transfer the Purchase Price in immediately available funds on the above-specified date of purchase to]: 
 [Account Name] 
 [Account No.] 
 [Bank Name & Address] 
 [ABA #] 
 Reference: 
 Telephone advice to: [Name] @ tel. no. ( ) 
 Please advise
[Name] at telephone no. ( )                          if any Conduit will not be making this purchase. 
 In connection with the Incremental Purchase to be made on the above listed “Date of Purchase” (the “Purchase Date”), the
Seller hereby certifies that the following statements are true on the date hereof, and will be true on the Purchase Date (before and after giving effect to the proposed Incremental Purchase): 
 (i) the representations and warranties of the Seller set forth in Section 5.1 and 5.2 of the Receivables Purchase Agreement are true and correct on
and as of the Purchase Date as though made on and as of such date; 
  

	 1
	 This amount will be equal to the BofA Conduit’s Pro Rata Share of the Purchase Price specified above.

	 2
	 This amount will be equal to the BTMU Conduit’s Pro Rata Share of the Purchase Price specified above.

	 3
	 This amount will be equal to the RBS Conduit’s Pro Rata
Share of the Purchase Price specified above. 

  

 Ex. II-2 

 (ii) no event has occurred and is continuing, or would result from the proposed Incremental Purchase,
that will constitute an Amortization Event or a Potential Amortization Event; 
 (iii) the Amortization Date has not occurred, the Aggregate
Capital does not exceed the Purchase Limit and the aggregate Purchaser Interests do not exceed 100%; and 
 (iv) the amount of Aggregate
Capital is $                     after giving effect to the Incremental Purchase to be made on the Purchase Date. 
  

			
	Very truly yours,
	
	CARDINAL HEALTH FUNDING, LLC
		
	By:	 	  

	Name:	 	
	Title:	 	
		
	Address:	 	

  

 Ex. II-3 

 EXHIBIT IX 
 FORM OF MONTHLY REPORT 
 (Attached) 
  

 Ex. IX-1 

 EXHIBIT XI 
 FORM OF REDUCTION NOTICE 
                     , 20     
 The Bank of Tokyo-Mitsubishi UFJ, Ltd., New York Branch, as Agent and a Managing Agent 
 12th Floor 
 1251 Avenue
of the Americas 
 New York, NY 10020 
 Attention: Hermina Batson

 The Royal Bank of Scotland plc, as a Managing Agent 
 540 West
Madison Street, 27th Floor 
 Chicago, IL 60661 
 Attention:
Kristina Neville, Sheila Brooks & Sharon Jones 
 Bank of America, N.A., as a Managing Agent 
 NC1-027-19-01 
 214 North Tryon Street 
 Charlotte, NC 28255 
 Attention: Nina Stevenson 
 Ladies and Gentlemen: 
 The undersigned,
                                        ,
refers to the Third Amended and Restated Receivables Purchase Agreement, dated as of November 19, 2007, as amended (the “Receivables Purchase Agreement”, the terms defined therein being used herein as therein defined), among
the undersigned, Griffin Capital, LLC, as Servicer ( “Servicer”), certain Conduits party thereto, certain Financial Institutions parties thereto, certain Managing Agents party thereto and The Bank of Tokyo-Mitsubishi UFJ, Ltd., New
York Branch, as Agent for such Conduits and Financial Institutions (the Conduits and the Financial Institutions, collectively, the “Purchasers”). Pursuant to Section 1.3 of the Receivables Purchase Agreement, the undersigned
hereby irrevocably notifies you that it will repay [all] [a portion] of the Capital outstanding under the Receivables Purchase Agreement and in that connection sets forth below the information relating to such repayment (the “Proposed
Reduction”): 
 The Business Day of the Proposed Reduction is
                    , 20    . 
 The total amount of the Proposed Reduction is
                                        .

 The Pro Rata Share of the Proposed Reduction for each Conduit is: 
  

	
	                                        
  for Ranger Funding Company LLC;

	                                        
  for Victory Receivables Corporation; and

	                                        
  for Windmill Funding Corporation.

  

 Ex. XI-1 

 The Pro Rata Share of the Proposed Reduction for each Financial Institution is:
                                        
for BofA,
                                        
for BTMU and
                                        
for RBS. 
 On the date of the Proposed Reduction, the Seller shall pay to each relevant Purchaser(s), an amount equal to (i) such
Purchaser’s Pro Rata Share of the outstanding Capital described above, plus (ii) all Broken Funding Costs (if any), plus (iii) all other amounts payable to the Agent or any Purchaser under the Transaction Documents. 
  

			
	Very truly yours,
	
	CARDINAL HEALTH FUNDING, LLC
		
	By:	 	  

	Name:	 	
	Title:	 	
	Address:	 	

  

 Ex. XI-2 

 EXHIBIT XII 
 [Reserved] 
  

 Ex. XII-1 

 SCHEDULE A 
 COMMITMENTS, CONDUIT PURCHASE LIMITS, WIRING INSTRUCTIONS, RELATED FINANCIAL INSTITUTIONS AND MANAGING AGENTS 
 Financial Institutions, Commitments and Wiring Instructions 
 for Financial Institutions 
  

						
	 Financial Institution
	  	Commitment	  	 Wiring Instructions for Payments to Financial Institutions

 (Wiring instructions for payments to Conduits are on the following page)

	 Bank of America, N.A., with respect to Ranger Funding Company LLC
	  	$	306,000,000	  	 For any up-front or closing fees, to the following account:
  
 Bank: Bank of America
 Benf: Asset Securitization Wire Clearing
 ABA: 026-009-593
 A/c# 109360-0656600
 Ref: Cardinal Health / Upfront
 Attn: Sean Walsh
  
 For any other payments, to the account specified for Ranger Funding Company, LLC on the following page.

			
	 The Bank of Tokyo-Mitsubishi UFJ, Ltd., acting through its New York Branch, with respect to Victory Receivables Corporation
	  	$	306,000,000	  	 The Bank of Tokyo-Mitsubishi UFJ, Ltd., New York Branch
 ABA#: 026-00963-2
 A/C #: 97770191
 Attn: Loan Operations Group
 Ref: Cardinal Health

			
	 The Royal Bank of Scotland plc, with respect to Windmill Funding Corporation
	  	$	255,000,000	  	 ABN AMRO Bank, N.V.
 New York, New York
 ABA#: 026 0095 80
 A/C Name: Windmill Funding Corporation
 A/C#: 451118894850
 Ref: Cardinal Health Funding LLC

  

 Sch. A-1 

 Conduit Purchase Limits, Wiring Instructions for Conduits and Related Financial Institutions of
Conduits 
  

								
	 Conduit
	  	Conduit
Purchase
Limit	  	 Wiring Instructions for Conduits
	  	 Related Financial Institution

	 Ranger Funding Company LLC
	  	$	300,000,000	  	 Ranger Funding Company LLC
 Bank: Deutsche Bank (New
York, NY)
 Benf: DTBCA as Agent for Ranger Funding
 ABA: 021 001
033
 A/C Name:
 A/C# 00 384 710
 Ref: Cardinal Health / Ongoing Fees
 Attn: Orinthia Skeete
	  	Bank of America, N.A.
				
	 Victory Receivables Corporation
	  	$	300,000,000	  	 Deutsche Bank Trust Company Americas
 ABA #: 021-001-033

 A/C Name: Corporate Trust & Agency Services
 A/C No.:
01419647
 Ref: Victory Receivables / Cardinal Health
	  	The Bank of Tokyo-Mitsubishi UFJ, Ltd., acting through its New York Branch
				
	 Windmill Funding Corporation
	  	$	250,000,000	  	 ABN AMRO Bank, N.V.
 New York, New York
 ABA#: 026 0095 80
 A/C Name: Windmill Funding Corporation
 A/C #: 451118894850
 Ref: Cardinal Health Funding LLC
	  	The Royal Bank of Scotland plc

  

 Sch. A-2 

 Managing Agents 
  

			
	 Purchasers
	  	 Managing Agent

	 Ranger Funding Company LLC, as Conduit
  
 Bank of America, N.A., as Financial
Institution
	  	Bank of America, N.A.
		
	 Victory Receivables Corporation, as Conduit
  
 The Bank of Tokyo-Mitsubishi UFJ, Ltd., acting through its
New York Branch, as Financial Institution
	  	The Bank of Tokyo-Mitsubishi UFJ, Ltd., New York Branch
		
	 Windmill Funding Corporation, as Conduit
  
 The Royal Bank of Scotland plc, as Financial Institution

	  	The Royal Bank of Scotland plc

 Purchaser Groups 
  

	
	 Ranger Funding Company LLC, as Conduit
  
 Bank of America, N.A, as Financial Institution and as Managing Agent

	
	 Victory Receivables Corporation, as Conduit
  
 The Bank of Tokyo-Mitsubishi UFJ, Ltd., acting through its New York Branch, as Financial Institution
  
 The Bank of Tokyo-Mitsubishi UFJ, Ltd., New York Branch, as Managing Agent

	
	 Windmill Funding Corporation, as Conduit
  
 The Royal Bank of Scotland plc, as Financial Institution and as Managing Agent

  

 Sch. A-3 

 Agent and Wiring Instructions for the Agent 
  

			
	 Agent
	  	 Wiring Instructions for Agent

	The Bank of Tokyo-Mitsubishi UFJ, Ltd., New York Branch	  	 The Bank of Tokyo-Mitsubishi UFJ, Ltd., New York Branch
 ABA#: 026-00963-2
 A/C #: 97770191
 Attn: Loan
Operations Group
 Ref: Cardinal Health

  

 Sch. A-4 

 SCHEDULE C 
 NOTICE ADDRESSES 
  

			
	 Seller:
	  	 Cardinal Health Funding, LLC
 7660 W. Cheyenne Avenue

		  	Suite 113
		  	Las Vegas, Nevada 89129
		  	Attention: Sharon Hasselbach
		
		  	with a copy to:
		  	Cardinal Health, Inc.
		  	7000 Cardinal Place
		  	Dublin, Ohio 43017
		  	Attention: Assistant General Counsel - Finance or, for purposes of Sections 3.3 and 4.2 only, Treasury (Fax No. 614/652-8639)
		
	 Servicer:
	  	 Griffin Capital, LLC
 7660 W. Cheyenne
Avenue

		  	Suite 113
		  	Las Vegas, Nevada 89129
		  	Attention: Sharon Hasselbach
		
		  	with a copy to:
		  	Cardinal Health, Inc.
		  	7000 Cardinal Place
		  	Dublin, Ohio 43017
		  	Attention: Assistant General Counsel - Finance
		
	 BofA:
	  	Bank of America, N.A.
		  	NC1-027-19-01
		  	214 North Tryon Street
		  	Charlotte, NC 28255
		  	Attn: Nina Stevenson
		  	Fax: 212-548-8891

  

 Sch. C-1 

			
	BofA Conduit:	  	Ranger Funding Company LLC
		  	c/o AMACAR Group, L.L.C.
		  	6525 Morrison Blvd., Suite 318
		  	Charlotte, North Carolina 28211
		  	Attn: Ms. Evelyn Echevarria
		  	Fax: (704) 365-1362
		
		  	(with a copy to BofA)

  

			
	BTMUNY and BTMU:	  	The Bank of Tokyo-Mitsubishi UFJ, Ltd.
		  	1251 Avenue of the Americas, 12th Floor
		  	New York, NY 10020
		  	Attn: Hermina Batson
		  	Fax: (212) 782-6998
		
	BTMU Conduit:	  	Victory Receivables Corporation
		  	c/o The Bank of Tokyo-Mitsubishi UFJ, Ltd.
		  	1251 Avenue of the Americas
		  	New York, NY 10020
		  	Attn: Aditya Reddy
		  	Fax: (212) 782-6448
		
		  	(with a copy to BTMUNY)
		
	RBS:	  	 The Royal Bank of Scotland plc
 540 W. Madison St.,
27th floor
 Chicago, IL 60661
 Attn: Kristina Neville

Fax: 312-338-0140
  
 (with a copy of any Purchase Notices or Reduction Notices to the RBS Conduit at its address below)

		
	RBS Conduit:	  	Windmill Funding Corporation
		  	c/o The Royal Bank of Scotland plc
		  	540 West Madison Street, 27th Floor
		  	Chicago, Illinois 60661
		  	Attention: Sheila Brooks / Sharon Jones
		  	Fax: 312-601-3616
		
		  	(with a copy to RBS)

  

 Sch. C-2Warrant to purchase Common Stock

 Exhibit 4.1 
 WARRANT TO PURCHASE COMMON STOCK 
 THE SECURITIES REPRESENTED BY THIS INSTRUMENT HAVE NOT BEEN REGISTERED UNDER THE
SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES LAWS OF ANY STATE AND MAY NOT BE TRANSFERRED, SOLD OR OTHERWISE DISPOSED OF EXCEPT WHILE A REGISTRATION STATEMENT RELATING THERETO IS IN EFFECT UNDER SUCH ACT AND APPLICABLE STATE SECURITIES LAWS
OR PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER SUCH ACT OR SUCH LAWS. THIS INSTRUMENT IS ISSUED SUBJECT TO THE RESTRICTIONS ON TRANSFER AND OTHER PROVISIONS OF A SECURITIES PURCHASE AGREEMENT BETWEEN THE ISSUER OF THESE SECURITIES AND THE
INVESTOR REFERRED TO THEREIN, A COPY OF WHICH IS ON FILE WITH THE ISSUER. THE SECURITIES REPRESENTED BY THIS INSTRUMENT MAY NOT BE SOLD OR OTHERWISE TRANSFERRED EXCEPT IN COMPLIANCE WITH SAID AGREEMENT. ANY SALE OR OTHER TRANSFER NOT IN COMPLIANCE
WITH SAID AGREEMENT WILL BE VOID. 
 WARRANT 
 to purchase 
 48,253,677 
 Shares of Common Stock of 
 REGIONS FINANCIAL CORPORATION 
 Issue Date: November 14, 2008 
 1.
Definitions. Unless the context otherwise requires, when used herein the following terms shall have the meanings indicated. 
 “Affiliate” has the meaning ascribed to it in the Purchase Agreement. 
 “Appraisal Procedure”
means a procedure whereby two independent appraisers, one chosen by the Company and one by the Original Warrantholder, shall mutually agree upon the determinations then the subject of appraisal. Each party shall deliver a notice to the other
appointing its appraiser within 15 days after the Appraisal Procedure is invoked. If within 30 days after appointment of the two appraisers they are unable to agree upon the amount in question, a third independent appraiser shall be chosen within 10
days thereafter by the mutual consent of such first two appraisers. The decision of the third appraiser so appointed and chosen shall be given within 30 days after the selection of such third appraiser. If three appraisers shall be appointed and the
determination of one appraiser is disparate from the middle determination by more than twice the amount by which the other determination is disparate from the middle determination, then the determination of such appraiser shall be excluded, the
remaining two determinations shall be averaged and such average shall be binding and conclusive upon the Company and the Original Warrantholder; otherwise, the average of all three determinations shall be binding upon the Company and the Original
Warrantholder. The costs of conducting any Appraisal Procedure shall be borne by the Company. 

 “Board of Directors” means the board of directors of the Company, including any duly
authorized committee thereof. 
 “Business Combination” means a merger, consolidation, statutory share exchange or similar
transaction that requires the approval of the Company’s stockholders. 
 “business day” means any day except Saturday,
Sunday and any day on which banking institutions in the State of New York generally are authorized or required by law or other governmental actions to close. 
 “Capital Stock” means (A) with respect to any Person that is a corporation or company, any and all shares, interests, participations or other equivalents (however designated) of capital or
capital stock of such Person and (B) with respect to any Person that is not a corporation or company, any and all partnership or other equity interests of such Person. 
 “Charter” means, with respect to any Person, its certificate or articles of incorporation, articles of association, or similar
organizational document. 
 “Common Stock” has the meaning ascribed to it in the Purchase Agreement. 
 “Company” means the Person whose name, corporate or other organizational form and jurisdiction of organization is set forth in
Item 1 of Schedule A hereto. 
 “conversion” has the meaning set forth in Section 13(B). 
 “convertible securities” has the meaning set forth in Section 13(B). 
 “CPP” has the meaning ascribed to it in the Purchase Agreement. 
 “Exchange Act” means the Securities Exchange Act of 1934, as amended, or any successor statute, and the rules and regulations
promulgated thereunder. 
 “Exercise Price” means the amount set forth in Item 2 of Schedule A hereto.

 “Expiration Time” has the meaning set forth in Section 3. 
 “Fair Market Value” means, with respect to any security or other property, the fair market value of such security or other property as
determined by the Board of Directors, acting in good faith or, with respect to Section 14, as determined by the Original Warrantholder acting in good faith. For so long as the Original Warrantholder holds this Warrant or any portion thereof, it
may object in writing to the Board of Director’s calculation of fair market value within 10 days of receipt of written notice thereof. If the Original Warrantholder and the Company are unable to agree on fair market value during the 10-day
period following the delivery of the Original Warrantholder’s objection, the Appraisal Procedure may be invoked by either party to determine Fair Market Value by delivering written notification thereof not later than the 30th day after delivery
of the Original Warrantholder’s objection. 
  

 2 

 “Governmental Entities” has the meaning ascribed to it in the Purchase Agreement.

 “Initial Number” has the meaning set forth in Section 13(B). 
 “Issue Date” means the date set forth in Item 3 of Schedule A hereto. 
 “Market Price” means, with respect to a particular security, on any given day, the last reported sale price regular way or, in case no
such reported sale takes place on such day, the average of the last closing bid and ask prices regular way, in either case on the principal national securities exchange on which the applicable securities are listed or admitted to trading, or if not
listed or admitted to trading on any national securities exchange, the average of the closing bid and ask prices as furnished by two members of the Financial Industry Regulatory Authority, Inc. selected from time to time by the Company for that
purpose. “Market Price” shall be determined without reference to after hours or extended hours trading. If such security is not listed and traded in a manner that the quotations referred to above are available for the period
required hereunder, the Market Price per share of Common Stock shall be deemed to be (i) in the event that any portion of the Warrant is held by the Original Warrantholder, the fair market value per share of such security as determined in good
faith by the Original Warrantholder or (ii) in all other circumstances, the fair market value per share of such security as determined in good faith by the Board of Directors in reliance on an opinion of a nationally recognized independent
investment banking corporation retained by the Company for this purpose and certified in a resolution to the Warrantholder. For the purposes of determining the Market Price of the Common Stock on the “trading day” preceding, on or
following the occurrence of an event, (i) that trading day shall be deemed to commence immediately after the regular scheduled closing time of trading on the New York Stock Exchange or, if trading is closed at an earlier time, such earlier time
and (ii) that trading day shall end at the next regular scheduled closing time, or if trading is closed at an earlier time, such earlier time (for the avoidance of doubt, and as an example, if the Market Price is to be determined as of the last
trading day preceding a specified event and the closing time of trading on a particular day is 4:00 p.m. and the specified event occurs at 5:00 p.m. on that day, the Market Price would be determined by reference to such 4:00 p.m. closing price).

 “Ordinary Cash Dividends” means a regular quarterly cash dividend on shares of Common Stock out of surplus or net profits
legally available therefor (determined in accordance with generally accepted accounting principles in effect from time to time), provided that Ordinary Cash Dividends shall not include any cash dividends paid subsequent to the Issue Date to
the extent the aggregate per share dividends paid on the outstanding Common Stock in any quarter exceed the amount set forth in Item 4 of Schedule A hereto, as adjusted for any stock split, stock dividend, reverse stock split,
reclassification or similar transaction. 
 “Original Warrantholder” means the United States Department of the Treasury. Any
actions specified to be taken by the Original Warrantholder hereunder may only be taken by such Person and not by any other Warrantholder. 
  

 3 

 “Permitted Transactions” has the meaning set forth in Section 13(B). 
 “Person” has the meaning given to it in Section 3(a)(9) of the Exchange Act and as used in Sections 13(d)(3) and 14(d)(2) of the
Exchange Act. 
 “Per Share Fair Market Value” has the meaning set forth in Section 13(C). 
 “Preferred Shares” means the perpetual preferred stock issued to the Original Warrantholder on the Issue Date pursuant to the Purchase
Agreement. 
 “Pro Rata Repurchases” means any purchase of shares of Common Stock by the Company or any Affiliate thereof
pursuant to (A) any tender offer or exchange offer subject to Section 13(e) or 14(e) of the Exchange Act or Regulation 14E promulgated thereunder or (B) any other offer available to substantially all holders of Common Stock, in the
case of both (A) or (B), whether for cash, shares of Capital Stock of the Company, other securities of the Company, evidences of indebtedness of the Company or any other Person or any other property (including, without limitation, shares of
Capital Stock, other securities or evidences of indebtedness of a subsidiary), or any combination thereof, effected while this Warrant is outstanding. The “Effective Date” of a Pro Rata Repurchase shall mean the date of acceptance
of shares for purchase or exchange by the Company under any tender or exchange offer which is a Pro Rata Repurchase or the date of purchase with respect to any Pro Rata Repurchase that is not a tender or exchange offer. 
 “Purchase Agreement” means the Securities Purchase Agreement – Standard Terms incorporated into the Letter Agreement, dated as of
the date set forth in Item 5 of Schedule A hereto, as amended from time to time, between the Company and the United States Department of the Treasury (the “Letter Agreement”), including all annexes and schedules thereto.

 “Qualified Equity Offering” has the meaning ascribed to it in the Purchase Agreement. 
 “Regulatory Approvals” with respect to the Warrantholder, means, to the extent applicable and required to permit the Warrantholder to
exercise this Warrant for shares of Common Stock and to own such Common Stock without the Warrantholder being in violation of applicable law, rule or regulation, the receipt of any necessary approvals and authorizations of, filings and registrations
with, notifications to, or expiration or termination of any applicable waiting period under, the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and the rules and regulations thereunder. 
 “SEC” means the U.S. Securities and Exchange Commission. 
 “Securities Act” means the Securities Act of 1933, as amended, or any successor statute, and the rules and regulations promulgated thereunder. 
 “Shares” has the meaning set forth in Section 2. 
 “trading day” means (A) if the shares of Common Stock are not traded on any national or regional securities exchange or association or over-the-counter market, a business day or (B) if the
shares of Common Stock are traded on any national or regional securities exchange or 

  

 4 

 
association or over-the-counter market, a business day on which such relevant exchange or quotation system is scheduled to be open for business and on which
the shares of Common Stock (i) are not suspended from trading on any national or regional securities exchange or association or over-the-counter market for any period or periods aggregating one half hour or longer; and (ii) have traded at
least once on the national or regional securities exchange or association or over-the-counter market that is the primary market for the trading of the shares of Common Stock. 
 “U.S. GAAP” means United States generally accepted accounting principles. 
 “Warrantholder” has the meaning set forth in Section 2. 
 “Warrant” means this Warrant, issued pursuant to the Purchase Agreement. 
 2. Number of Shares; Exercise Price. This certifies that, for value received, the United States Department of the Treasury or its permitted
assigns (the “Warrantholder”) is entitled, upon the terms and subject to the conditions hereinafter set forth, to acquire from the Company, in whole or in part, after the receipt of all applicable Regulatory Approvals, if any, up to
an aggregate of the number of fully paid and nonassessable shares of Common Stock set forth in Item 6 of Schedule A hereto, at a purchase price per share of Common Stock equal to the Exercise Price. The number of shares of Common Stock
(the “Shares”) and the Exercise Price are subject to adjustment as provided herein, and all references to “Common Stock,” “Shares” and “Exercise Price” herein shall be deemed to
include any such adjustment or series of adjustments. 
 3. Exercise of Warrant; Term. Subject to Section 2, to the extent
permitted by applicable laws and regulations, the right to purchase the Shares represented by this Warrant is exercisable, in whole or in part by the Warrantholder, at any time or from time to time after the execution and delivery of this Warrant by
the Company on the date hereof, but in no event later than 5:00 p.m., New York City time on the tenth anniversary of the Issue Date (the “Expiration Time”), by (A) the surrender of this Warrant and Notice of Exercise annexed
hereto, duly completed and executed on behalf of the Warrantholder, at the principal executive office of the Company located at the address set forth in Item 7 of Schedule A hereto (or such other office or agency of the Company in the
United States as it may designate by notice in writing to the Warrantholder at the address of the Warrantholder appearing on the books of the Company), and (B) payment of the Exercise Price for the Shares thereby purchased: 
 (i) by having the Company withhold, from the shares of Common Stock that would otherwise be delivered to the Warrantholder upon such
exercise, shares of Common stock issuable upon exercise of the Warrant equal in value to the aggregate Exercise Price as to which this Warrant is so exercised based on the Market Price of the Common Stock on the trading day on which this Warrant is
exercised and the Notice of Exercise is delivered to the Company pursuant to this Section 3, or 
 (ii) with the consent
of both the Company and the Warrantholder, by tendering in cash, by certified or cashier’s check payable to the order of the Company, or by wire transfer of immediately available funds to an account designated by the Company. 
  

 5 

 If the Warrantholder does not exercise this Warrant in its entirety, the Warrantholder will be entitled
to receive from the Company within a reasonable time, and in any event not exceeding three business days, a new warrant in substantially identical form for the purchase of that number of Shares equal to the difference between the number of Shares
subject to this Warrant and the number of Shares as to which this Warrant is so exercised. Notwithstanding anything in this Warrant to the contrary, the Warrantholder hereby acknowledges and agrees that its exercise of this Warrant for Shares is
subject to the condition that the Warrantholder will have first received any applicable Regulatory Approvals. 
 4. Issuance of Shares;
Authorization; Listing. Certificates for Shares issued upon exercise of this Warrant will be issued in such name or names as the Warrantholder may designate and will be delivered to such named Person or Persons within a reasonable time, not to
exceed three business days after the date on which this Warrant has been duly exercised in accordance with the terms of this Warrant. The Company hereby represents and warrants that any Shares issued upon the exercise of this Warrant in accordance
with the provisions of Section 3 will be duly and validly authorized and issued, fully paid and nonassessable and free from all taxes, liens and charges (other than liens or charges created by the Warrantholder, income and franchise taxes
incurred in connection with the exercise of the Warrant or taxes in respect of any transfer occurring contemporaneously therewith). The Company agrees that the Shares so issued will be deemed to have been issued to the Warrantholder as of the close
of business on the date on which this Warrant and payment of the Exercise Price are delivered to the Company in accordance with the terms of this Warrant, notwithstanding that the stock transfer books of the Company may then be closed or
certificates representing such Shares may not be actually delivered on such date. The Company will at all times reserve and keep available, out of its authorized but unissued Common Stock, solely for the purpose of providing for the exercise of this
Warrant, the aggregate number of shares of Common Stock then issuable upon exercise of this Warrant at any time. The Company will (A) procure, at its sole expense, the listing of the Shares issuable upon exercise of this Warrant at any time,
subject to issuance or notice of issuance, on all principal stock exchanges on which the Common Stock is then listed or traded and (B) maintain such listings of such Shares at all times after issuance. The Company will use reasonable best
efforts to ensure that the Shares may be issued without violation of any applicable law or regulation or of any requirement of any securities exchange on which the Shares are listed or traded. 
 5. No Fractional Shares or Scrip. No fractional Shares or scrip representing fractional Shares shall be issued upon any exercise of this Warrant.
In lieu of any fractional Share to which the Warrantholder would otherwise be entitled, the Warrantholder shall be entitled to receive a cash payment equal to the Market Price of the Common Stock on the last trading day preceding the date of
exercise less the pro-rated Exercise Price for such fractional share. 
 6. No Rights as Stockholders; Transfer Books. This Warrant
does not entitle the Warrantholder to any voting rights or other rights as a stockholder of the Company prior to the date of exercise hereof. The Company will at no time close its transfer books against transfer of this Warrant in any manner which
interferes with the timely exercise of this Warrant. 
  

 6 

 7. Charges, Taxes and Expenses. Issuance of certificates for Shares to the Warrantholder upon the
exercise of this Warrant shall be made without charge to the Warrantholder for any issue or transfer tax or other incidental expense in respect of the issuance of such certificates, all of which taxes and expenses shall be paid by the Company.

 8. Transfer/Assignment. 
 (A) Subject to compliance with clause (B) of this Section 8, this Warrant and all rights hereunder are transferable, in whole or in part, upon the books of the Company by the registered holder hereof in
person or by duly authorized attorney, and a new warrant shall be made and delivered by the Company, of the same tenor and date as this Warrant but registered in the name of one or more transferees, upon surrender of this Warrant, duly endorsed, to
the office or agency of the Company described in Section 3. All expenses (other than stock transfer taxes) and other charges payable in connection with the preparation, execution and delivery of the new warrants pursuant to this Section 8
shall be paid by the Company. 
 (B) The transfer of the Warrant and the Shares issued upon exercise of the Warrant are
subject to the restrictions set forth in Section 4.4 of the Purchase Agreement. If and for so long as required by the Purchase Agreement, this Warrant shall contain the legends as set forth in Sections 4.2(a) and 4.2(b) of the Purchase
Agreement. 
 9. Exchange and Registry of Warrant. This Warrant is exchangeable, upon the surrender hereof by the Warrantholder to the
Company, for a new warrant or warrants of like tenor and representing the right to purchase the same aggregate number of Shares. The Company shall maintain a registry showing the name and address of the Warrantholder as the registered holder of this
Warrant. This Warrant may be surrendered for exchange or exercise in accordance with its terms, at the office of the Company, and the Company shall be entitled to rely in all respects, prior to written notice to the contrary, upon such registry.

 10. Loss, Theft, Destruction or Mutilation of Warrant. Upon receipt by the Company of evidence reasonably satisfactory to it of the
loss, theft, destruction or mutilation of this Warrant, and in the case of any such loss, theft or destruction, upon receipt of a bond, indemnity or security reasonably satisfactory to the Company, or, in the case of any such mutilation, upon
surrender and cancellation of this Warrant, the Company shall make and deliver, in lieu of such lost, stolen, destroyed or mutilated Warrant, a new Warrant of like tenor and representing the right to purchase the same aggregate number of Shares as
provided for in such lost, stolen, destroyed or mutilated Warrant. 
 11. Saturdays, Sundays, Holidays, etc. If the last or appointed
day for the taking of any action or the expiration of any right required or granted herein shall not be a business day, then such action may be taken or such right may be exercised on the next succeeding day that is a business day. 
 12. Rule 144 Information. The Company covenants that it will use its reasonable best efforts to timely file all reports and other documents
required to be filed by it under the Securities Act and the Exchange Act and the rules and regulations promulgated by the SEC thereunder (or, if the Company is not required to file such reports, it will, upon the request of any 

  

 7 

 
Warrantholder, make publicly available such information as necessary to permit sales pursuant to Rule 144 under the Securities Act), and it will use
reasonable best efforts to take such further action as any Warrantholder may reasonably request, in each case to the extent required from time to time to enable such holder to, if permitted by the terms of this Warrant and the Purchase Agreement,
sell this Warrant without registration under the Securities Act within the limitation of the exemptions provided by (A) Rule 144 under the Securities Act, as such rule may be amended from time to time, or (B) any successor rule or
regulation hereafter adopted by the SEC. Upon the written request of any Warrantholder, the Company will deliver to such Warrantholder a written statement that it has complied with such requirements. 
 13. Adjustments and Other Rights. The Exercise Price and the number of Shares issuable upon exercise of this Warrant shall be subject to
adjustment from time to time as follows; provided, that if more than one subsection of this Section 13 is applicable to a single event, the subsection shall be applied that produces the largest adjustment and no single event shall cause
an adjustment under more than one subsection of this Section 13 so as to result in duplication: 
 (A) Stock Splits,
Subdivisions, Reclassifications or Combinations. If the Company shall (i) declare and pay a dividend or make a distribution on its Common Stock in shares of Common Stock, (ii) subdivide or reclassify the outstanding shares of Common
Stock into a greater number of shares, or (iii) combine or reclassify the outstanding shares of Common Stock into a smaller number of shares, the number of Shares issuable upon exercise of this Warrant at the time of the record date for such
dividend or distribution or the effective date of such subdivision, combination or reclassification shall be proportionately adjusted so that the Warrantholder after such date shall be entitled to purchase the number of shares of Common Stock which
such holder would have owned or been entitled to receive in respect of the shares of Common Stock subject to this Warrant after such date had this Warrant been exercised immediately prior to such date. In such event, the Exercise Price in effect at
the time of the record date for such dividend or distribution or the effective date of such subdivision, combination or reclassification shall be adjusted to the number obtained by dividing (x) the product of (1) the number of Shares
issuable upon the exercise of this Warrant before such adjustment and (2) the Exercise Price in effect immediately prior to the record or effective date, as the case may be, for the dividend, distribution, subdivision, combination or
reclassification giving rise to this adjustment by (y) the new number of Shares issuable upon exercise of the Warrant determined pursuant to the immediately preceding sentence. 
 (B) Certain Issuances of Common Shares or Convertible Securities. Until the earlier of (i) the date on which the Original
Warrantholder no longer holds this Warrant or any portion thereof and (ii) the third anniversary of the Issue Date, if the Company shall issue shares of Common Stock (or rights or warrants or other securities exercisable or convertible into or
exchangeable (collectively, a “conversion”) for shares of Common Stock) (collectively, “convertible securities”) (other than in Permitted Transactions (as defined below) or a transaction to which subsection
(A) of this Section 13 is applicable) without consideration or at a consideration per share (or having a conversion price per share) that is less than 90% of the Market Price on the last trading day preceding the date of the agreement on
pricing such shares (or such convertible securities) then, in such event: 
  

 8 

 (A) the number of Shares issuable upon the exercise of this Warrant immediately prior to the date of the
agreement on pricing of such shares (or of such convertible securities) (the “Initial Number”) shall be increased to the number obtained by multiplying the Initial Number by a fraction (A) the numerator of which shall be the
sum of (x) the number of shares of Common Stock of the Company outstanding on such date and (y) the number of additional shares of Common Stock issued (or into which convertible securities may be exercised or convert) and (B) the
denominator of which shall be the sum of (I) the number of shares of Common Stock outstanding on such date and (II) the number of shares of Common Stock which the aggregate consideration receivable by the Company for the total number of shares
of Common Stock so issued (or into which convertible securities may be exercised or convert) would purchase at the Market Price on the last trading day preceding the date of the agreement on pricing such shares (or such convertible securities); and

 (B) the Exercise Price payable upon exercise of the Warrant shall be adjusted by multiplying such Exercise Price in effect immediately
prior to the date of the agreement on pricing of such shares (or of such convertible securities) by a fraction, the numerator of which shall be the number of shares of Common Stock issuable upon exercise of this Warrant prior to such date and the
denominator of which shall be the number of shares of Common Stock issuable upon exercise of this Warrant immediately after the adjustment described in clause (A) above. 
 For purposes of the foregoing, the aggregate consideration receivable by the Company in connection with the issuance of such shares of Common Stock or
convertible securities shall be deemed to be equal to the sum of the net offering price (including the Fair Market Value of any non-cash consideration and after deduction of any related expenses payable to third parties) of all such securities plus
the minimum aggregate amount, if any, payable upon exercise or conversion of any such convertible securities into shares of Common Stock; and “Permitted Transactions” shall mean issuances (i) as consideration for or to fund the
acquisition of businesses and/or related assets, (ii) in connection with employee benefit plans and compensation related arrangements in the ordinary course and consistent with past practice approved by the Board of Directors, (iii) in
connection with a public or broadly marketed offering and sale of Common Stock or convertible securities for cash conducted by the Company or its affiliates pursuant to registration under the Securities Act or Rule 144A thereunder on a basis
consistent with capital raising transactions by comparable financial institutions and (iv) in connection with the exercise of preemptive rights on terms existing as of the Issue Date. Any adjustment made pursuant to this Section 13(B)
shall become effective immediately upon the date of such issuance. 
 (C) Other Distributions. In case the Company
shall fix a record date for the making of a distribution to all holders of shares of its Common Stock of securities, evidences of indebtedness, assets, cash, rights or warrants (excluding Ordinary Cash Dividends, dividends of its Common Stock and
other dividends or distributions referred to in Section 13(A)), in each such case, the Exercise Price in effect prior to such record date shall be reduced immediately thereafter to the price determined by multiplying the Exercise Price in
effect immediately prior to the reduction by the quotient of (x) the Market Price of the Common Stock on the last trading day preceding the first date on which the Common Stock trades regular way on the principal 

  

 9 

 
national securities exchange on which the Common Stock is listed or admitted to trading without the right to receive such distribution, minus the amount of
cash and/or the Fair Market Value of the securities, evidences of indebtedness, assets, rights or warrants to be so distributed in respect of one share of Common Stock (such amount and/or Fair Market Value, the “Per Share Fair Market
Value”) divided by (y) such Market Price on such date specified in clause (x); such adjustment shall be made successively whenever such a record date is fixed. In such event, the number of Shares issuable upon the exercise of this
Warrant shall be increased to the number obtained by dividing (x) the product of (1) the number of Shares issuable upon the exercise of this Warrant before such adjustment, and (2) the Exercise Price in effect immediately prior to the
distribution giving rise to this adjustment by (y) the new Exercise Price determined in accordance with the immediately preceding sentence. In the case of adjustment for a cash dividend that is, or is coincident with, a regular quarterly cash
dividend, the Per Share Fair Market Value would be reduced by the per share amount of the portion of the cash dividend that would constitute an Ordinary Cash Dividend. In the event that such distribution is not so made, the Exercise Price and the
number of Shares issuable upon exercise of this Warrant then in effect shall be readjusted, effective as of the date when the Board of Directors determines not to distribute such shares, evidences of indebtedness, assets, rights, cash or warrants,
as the case may be, to the Exercise Price that would then be in effect and the number of Shares that would then be issuable upon exercise of this Warrant if such record date had not been fixed. 
 (D) Certain Repurchases of Common Stock. In case the Company effects a Pro Rata Repurchase of Common Stock, then the Exercise Price
shall be reduced to the price determined by multiplying the Exercise Price in effect immediately prior to the Effective Date of such Pro Rata Repurchase by a fraction of which the numerator shall be (i) the product of (x) the number of
shares of Common Stock outstanding immediately before such Pro Rata Repurchase and (y) the Market Price of a share of Common Stock on the trading day immediately preceding the first public announcement by the Company or any of its Affiliates of
the intent to effect such Pro Rata Repurchase, minus (ii) the aggregate purchase price of the Pro Rata Repurchase, and of which the denominator shall be the product of (i) the number of shares of Common Stock outstanding immediately prior
to such Pro Rata Repurchase minus the number of shares of Common Stock so repurchased and (ii) the Market Price per share of Common Stock on the trading day immediately preceding the first public announcement by the Company or any of its
Affiliates of the intent to effect such Pro Rata Repurchase. In such event, the number of shares of Common Stock issuable upon the exercise of this Warrant shall be increased to the number obtained by dividing (x) the product of (1) the
number of Shares issuable upon the exercise of this Warrant before such adjustment, and (2) the Exercise Price in effect immediately prior to the Pro Rata Repurchase giving rise to this adjustment by (y) the new Exercise Price determined
in accordance with the immediately preceding sentence. For the avoidance of doubt, no increase to the Exercise Price or decrease in the number of Shares issuable upon exercise of this Warrant shall be made pursuant to this Section 13(D).

 (E) Business Combinations. In case of any Business Combination or reclassification of Common Stock (other than a
reclassification of Common Stock referred to in Section 13(A)), the Warrantholder’s right to receive Shares upon exercise of this Warrant shall be converted into the right to exercise this Warrant to acquire the number of shares of stock
or other securities or property (including cash) which the Common Stock issuable (at the time of such Business Combination or reclassification) upon exercise of this Warrant immediately prior 

  

 10 

 
to such Business Combination or reclassification would have been entitled to receive upon consummation of such Business Combination or reclassification; and
in any such case, if necessary, the provisions set forth herein with respect to the rights and interests thereafter of the Warrantholder shall be appropriately adjusted so as to be applicable, as nearly as may reasonably be, to the
Warrantholder’s right to exercise this Warrant in exchange for any shares of stock or other securities or property pursuant to this paragraph. In determining the kind and amount of stock, securities or the property receivable upon exercise of
this Warrant following the consummation of such Business Combination, if the holders of Common Stock have the right to elect the kind or amount of consideration receivable upon consummation of such Business Combination, then the consideration that
the Warrantholder shall be entitled to receive upon exercise shall be deemed to be the types and amounts of consideration received by the majority of all holders of the shares of common stock that affirmatively make an election (or of all such
holders if none make an election). 
 (F) Rounding of Calculations; Minimum Adjustments. All calculations under this
Section 13 shall be made to the nearest one-tenth (1/10th) of a cent or to the nearest one-hundredth (1/100th) of a share, as the case may be. Any provision of this Section 13 to the contrary notwithstanding, no adjustment in the
Exercise Price or the number of Shares into which this Warrant is exercisable shall be made if the amount of such adjustment would be less than $0.01 or one-tenth (1/10th) of a share of Common Stock, but any such amount shall be carried forward
and an adjustment with respect thereto shall be made at the time of and together with any subsequent adjustment which, together with such amount and any other amount or amounts so carried forward, shall aggregate $0.01 or 1/10th of a share of Common
Stock, or more. 
 (G) Timing of Issuance of Additional Common Stock Upon Certain Adjustments. In any case in which the
provisions of this Section 13 shall require that an adjustment shall become effective immediately after a record date for an event, the Company may defer until the occurrence of such event (i) issuing to the Warrantholder of this Warrant
exercised after such record date and before the occurrence of such event the additional shares of Common Stock issuable upon such exercise by reason of the adjustment required by such event over and above the shares of Common Stock issuable upon
such exercise before giving effect to such adjustment and (ii) paying to such Warrantholder any amount of cash in lieu of a fractional share of Common Stock; provided, however, that the Company upon request shall deliver to such
Warrantholder a due bill or other appropriate instrument evidencing such Warrantholder’s right to receive such additional shares, and such cash, upon the occurrence of the event requiring such adjustment. 
 (H) Completion of Qualified Equity Offering. In the event the Company (or any successor by Business Combination) completes one or
more Qualified Equity Offerings on or prior to December 31, 2009 that result in the Company (or any such successor ) receiving aggregate gross proceeds of not less than 100% of the aggregate liquidation preference of the Preferred Shares (and
any preferred stock issued by any such successor to the Original Warrantholder under the CPP), the number of shares of Common Stock underlying the portion of this Warrant then held by the Original Warrantholder shall be thereafter reduced by a
number of shares of Common Stock equal to the product of (i) 0.5 and (ii) the number of shares underlying the Warrant on the Issue Date (adjusted to take into account all other theretofore made adjustments pursuant to this
Section 13). 
  

 11 

 (I) Other Events. For so long as the Original Warrantholder holds this Warrant or
any portion thereof, if any event occurs as to which the provisions of this Section 13 are not strictly applicable or, if strictly applicable, would not, in the good faith judgment of the Board of Directors of the Company, fairly and adequately
protect the purchase rights of the Warrants in accordance with the essential intent and principles of such provisions, then the Board of Directors shall make such adjustments in the application of such provisions, in accordance with such essential
intent and principles, as shall be reasonably necessary, in the good faith opinion of the Board of Directors, to protect such purchase rights as aforesaid. The Exercise Price or the number of Shares into which this Warrant is exercisable shall not
be adjusted in the event of a change in the par value of the Common Stock or a change in the jurisdiction of incorporation of the Company. 
 (J) Statement Regarding Adjustments. Whenever the Exercise Price or the number of Shares into which this Warrant is exercisable shall be adjusted as provided in Section 13, the Company shall forthwith file
at the principal office of the Company a statement showing in reasonable detail the facts requiring such adjustment and the Exercise Price that shall be in effect and the number of Shares into which this Warrant shall be exercisable after such
adjustment, and the Company shall also cause a copy of such statement to be sent by mail, first class postage prepaid, to each Warrantholder at the address appearing in the Company’s records. 
 (K) Notice of Adjustment Event. In the event that the Company shall propose to take any action of the type described in this
Section 13 (but only if the action of the type described in this Section 13 would result in an adjustment in the Exercise Price or the number of Shares into which this Warrant is exercisable or a change in the type of securities or
property to be delivered upon exercise of this Warrant), the Company shall give notice to the Warrantholder, in the manner set forth in Section 13(J), which notice shall specify the record date, if any, with respect to any such action and the
approximate date on which such action is to take place. Such notice shall also set forth the facts with respect thereto as shall be reasonably necessary to indicate the effect on the Exercise Price and the number, kind or class of shares or other
securities or property which shall be deliverable upon exercise of this Warrant. In the case of any action which would require the fixing of a record date, such notice shall be given at least 10 days prior to the date so fixed, and in case of all
other action, such notice shall be given at least 15 days prior to the taking of such proposed action. Failure to give such notice, or any defect therein, shall not affect the legality or validity of any such action. 
 (L) Proceedings Prior to Any Action Requiring Adjustment. As a condition precedent to the taking of any action which would require
an adjustment pursuant to this Section 13, the Company shall take any action which may be necessary, including obtaining regulatory, New York Stock Exchange, NASDAQ Stock Market or other applicable national securities exchange or stockholder
approvals or exemptions, in order that the Company may thereafter validly and legally issue as fully paid and nonassessable all shares of Common Stock that the Warrantholder is entitled to receive upon exercise of this Warrant pursuant to this
Section 13. 
  

 12 

 (M) Adjustment Rules. Any adjustments pursuant to this Section 13 shall be
made successively whenever an event referred to herein shall occur. If an adjustment in Exercise Price made hereunder would reduce the Exercise Price to an amount below par value of the Common Stock, then such adjustment in Exercise Price made
hereunder shall reduce the Exercise Price to the par value of the Common Stock. 
 14. Exchange. At any time following the date on
which the shares of Common Stock of the Company are no longer listed or admitted to trading on a national securities exchange (other than in connection with any Business Combination), the Original Warrantholder may cause the Company to exchange all
or a portion of this Warrant for an economic interest (to be determined by the Original Warrantholder after consultation with the Company) of the Company classified as permanent equity under U.S. GAAP having a value equal to the Fair Market Value of
the portion of the Warrant so exchanged. The Original Warrantholder shall calculate any Fair Market Value required to be calculated pursuant to this Section 14, which shall not be subject to the Appraisal Procedure. 
 15. No Impairment. The Company will not, by amendment of its Charter or through any reorganization, transfer of assets, consolidation, merger,
dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms to be observed or performed hereunder by the Company, but will at all times in good faith assist in the
carrying out of all the provisions of this Warrant and in taking of all such action as may be necessary or appropriate in order to protect the rights of the Warrantholder. 
 16. Governing Law. This Warrant will be governed by and construed in accordance with the federal law of the United States if and to the extent
such law is applicable, and otherwise in accordance with the laws of the State of New York applicable to contracts made and to be performed entirely within such State. Each of the Company and the Warrantholder agrees (a) to submit to the
exclusive jurisdiction and venue of the United States District Court for the District of Columbia for any civil action, suit or proceeding arising out of or relating to this Warrant or the transactions contemplated hereby, and (b) that notice
may be served upon the Company at the address in Section 20 below and upon the Warrantholder at the address for the Warrantholder set forth in the registry maintained by the Company pursuant to Section 9 hereof. To the extent permitted by
applicable law, each of the Company and the Warrantholder hereby unconditionally waives trial by jury in any civil legal action or proceeding relating to the Warrant or the transactions contemplated hereby or thereby. 
 17. Binding Effect. This Warrant shall be binding upon any successors or assigns of the Company. 
 18. Amendments. This Warrant may be amended and the observance of any term of this Warrant may be waived only with the written consent of the
Company and the Warrantholder. 
 19. Prohibited Actions. The Company agrees that it will not take any action which would entitle the
Warrantholder to an adjustment of the Exercise Price if the total number of shares of Common Stock issuable after such action upon exercise of this Warrant, together with 

  

 13 

 
all shares of Common Stock then outstanding and all shares of Common Stock then issuable upon the exercise of all outstanding options, warrants, conversion
and other rights, would exceed the total number of shares of Common Stock then authorized by its Charter. 
 20. Notices. Any notice,
request, instruction or other document to be given hereunder by any party to the other will be in writing and will be deemed to have been duly given (a) on the date of delivery if delivered personally, or by facsimile, upon confirmation of
receipt, or (b) on the second business day following the date of dispatch if delivered by a recognized next day courier service. All notices hereunder shall be delivered as set forth in Item 8 of Schedule A hereto, or pursuant to
such other instructions as may be designated in writing by the party to receive such notice. 
 21. Entire Agreement. This Warrant,
the forms attached hereto and Schedule A hereto (the terms of which are incorporated by reference herein), and the Letter Agreement (including all documents incorporated therein), contain the entire agreement between the parties with respect
to the subject matter hereof and supersede all prior and contemporaneous arrangements or undertakings with respect thereto. 
 [Remainder
of page intentionally left blank] 
  

 14 

 [Form of Notice of Exercise] 
 Date:              
  

			
	TO:	  	REGIONS FINANCIAL CORPORATION
		
	RE:	  	Election to Purchase Common Stock

 The undersigned, pursuant to the provisions set forth in the attached Warrant, hereby agrees to
subscribe for and purchase the number of shares of the Common Stock set forth below covered by such Warrant. The undersigned, in accordance with Section 3 of the Warrant, hereby agrees to pay the aggregate Exercise Price for such shares of
Common Stock in the manner set forth below. A new warrant evidencing the remaining shares of Common Stock covered by such Warrant, but not yet subscribed for and purchased, if any, should be issued in the name set forth below. 
 Number of Shares of Common Stock
                             
 Method of Payment of Exercise Price (note if cashless exercise pursuant to Section 3(i) of the Warrant or cash exercise pursuant to Section 3(ii) of the Warrant, with consent of the Company and the
Warrantholder)                              
 Aggregate Exercise Price:
                                 
  

			
	Holder:	 	 
	 By:
	 	 
	 Name:
	 	 
	 Title:
	 	 

  

 15 

 IN WITNESS WHEREOF, the Company has caused this Warrant to be duly executed by a duly authorized officer.

 Dated: November 14, 2008 
  

					
	COMPANY:	 	REGIONS FINANCIAL CORPORATION
		
	By:	 	/s/ Hardie B. Kimbrough, Jr.
		 	Name:	 	Hardie B. Kimbrough, Jr.
		 	Title:	 	Executive Vice President and Controller
	Attest:	 		 	
		
	By:	 	/s/ List Underwood
		 	Name:	 	List Underwood
		 	Title:	 	Executive Vice President

 [Signature Page to Warrant] 
  

 16 

 SCHEDULE A 
 Item 1 
 Name: Regions Financial Corporation 
 Corporate or other organizational form: Corporation 
 Jurisdiction of organization: Delaware 
 Item 2 
 Exercise Price: $10.88 
 Item 3 
 Issue Date: November 14, 2008 
 Item 4 
 Amount of last dividend declared prior to the Issue
Date: $0.10 
 Item 5 
 Date of Letter Agreement
between the Company and the United States Department of the Treasury: November 14, 2008 
 Item 6 
 Number of shares of Common Stock: 48,253,677 
 Item 7 

Company’s address: 
 Regions Financial Corporation 
 1900 Fifth Avenue North 
 Birmingham, Alabama 35203 
 Item 8 
 Notice information: 
 If to the Company: 
 Regions Financial Corporation 

1900 Fifth Avenue North 
 Birmingham,
Alabama 35203 
 Attention: General Counsel 
 Telephone: (xxx) xxx-xxxx 
 Facsimile: (xxx) xxx-xxxx 
 With a copy to: 
 Sullivan & Cromwell
LLP 
 125 Broad Street 
 New
York, New York 10004 
 Attention: Andrew D. Soussloff 
 Telephone: (212) 558-4000 
 Facsimile: (212) 558-3588 

 SCHEDULE A 
 If to the Warrantholder: 
 United States Department of the Treasury 
 1500 Pennsylvania Avenue, NW, Room 2312 
 Washington, D.C. 20220 
 Attention: Assistant General Counsel (Banking and Finance) 
 Facsimile: (202) 622-1974

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00149-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00149-of-00352.parquet"}]]